Clinical trial phases
Also called: Phase 1 trial, Phase I-III trials · Topic: Human Capital: Education, Health and Demographic Dividend · NCERT: Beyond NCERT
Meaning
Clinical trial phases are the steps a new vaccine or medicine goes through when it is tested on people. Each step is bigger than the one before, and each asks a different question:
- Phase 1 gives the product to a small group of healthy volunteers. It checks whether the product is safe and what dose people can take.
- Phase 2 tests it on a larger group, often people who have the disease. It fine-tunes the dose, watches for side effects and looks for early signs that it works.
- Phase 3 tests it on a very large group, usually against a placebo (a dummy dose) or an existing treatment. This shows whether it really protects or cures.
After phase 3, the national regulator decides whether to approve the product. In India the regulator is the Drugs Controller General of India. The phases matter because they keep unsafe or useless products away from the public. They also take years and cost a lot, and that delay is why a new vaccine is rarely ready when an outbreak first hits.
Example
Bharat Biotech's Covaxin, an Indian COVID-19 vaccine, went through phase 1, phase 2 and then a large phase 3 trial run in many Indian cities. The phase 3 trial was the stage that measured how well the vaccine protected people.
Don't confuse with
- Preclinical testing: lab and animal studies done before phase 1. No human is involved yet.
- Phase 4 (post-marketing surveillance): monitoring that happens after approval, while the public is already using the product. It looks for rare or long-term side effects.